Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation

Journal of Hepatology

Volumn 58, Issue 5, 2013, Pages 969-976

  Biggins, Scott W ^a   Trotter, James ^b   Gralla, Jane ^a   Burton Jr , James R ^a   Bambha, Kiran M ^a   Dodge, Jennifer ^c   Brocato, Megan ^a   Cheng, Linling ^a   McQueen, Matt ^d   Forman, Lisa ^a   Chang, Michael ^e   Kam, Igal ^a   Everson, Gregory ^a   Spritz, Richard A ^a   Klintmalm, Goran ^b   Rosen, Hugo R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Clinical outcomes; Donor recipient matching; Gene polymorphisms; Hepatitis C recurrence; IL28B; Liver transplant

Indexed keywords

DNA; INTERLEUKIN 28B; RETINOIC ACID INDUCIBLE PROTEIN I;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BIOPSY; CASE-CONTROL STUDIES; DEAD-BOX RNA HELICASES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C; HUMANS; INTERLEUKINS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TRANSPLANTATION;

EID: 84876284476     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.12.027     Document Type: Article

References (36)

1. M. Berenguer, L. Ferrell, J. Watson, M. Prieto, M. Kim, and M. Rayon HCV-related fibrosis progression following liver transplantation: increase in recent years J Hepatol 32 2000 673 684
2. E.J. Gane, B.C. Portmann, N.V. Naoumov, H.M. Smith, J.A. Underhill, and P.T. Donaldson Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815 820
3. A. Sanchez-Fueyo, J.C. Restrepo, L. Quinto, M. Bruguera, L. Grande, and J.M. Sanchez-Tapias Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft Transplantation 73 2002 56 63
4. V. Garg, R. van Heeswijk, J.E. Lee, K. Alves, P. Nadkarni, and X. Luo Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus Hepatology 54 2011 20 27
5. M. Charlton Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents - a potentially lethal cocktail Hepatology 54 2011 3 5
6. T. Asselah A sprint to increase response to HCV treatment: expectancies but caution J Hepatol 55 2011 1154 1158
7. T. Asselah Realize the advance in HCV treatment, but remain cautious J Hepatol 55 2011 1457 1460
8. A. Rauch, Z. Kutalik, P. Descombes, T. Cai, J. Di Iulio, and T. Mueller Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345 [1345 e1331-1337]
9. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, and C. O'Huigin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
10. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
11. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
12. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
13. H.R. Rosen Clinical practice. Chronic hepatitis C infection N Engl J Med 364 2011 2429 2438
14. J. Hu, E. Nistal-Villan, A. Voho, A. Ganee, M. Kumar, and Y. Ding A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells J Immunol 185 2010 424 432
15. J. Pothlichet, A. Burtey, A.V. Kubarenko, G. Caignard, B. Solhonne, and F. Tangy Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response PLoS One 4 2009 e7582
16. S.M. Horner, and M. Gale Jr. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus J Interferon Cytokine Res 29 2009 489 498
17. M.R. Charlton, A. Thompson, B.J. Veldt, K. Watt, H. Tillmann, and J.J. Poterucha Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection Hepatology 53 2011 317 324
18. M. Coto-Llerena, S. Perez-Del-Pulgar, G. Crespo, J.A. Carrion, S.M. Martinez, and J.M. Sanchez-Tapias Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation Am J Transplant 11 2011 1051 1057
19. T. Fukuhara, A. Taketomi, T. Motomura, S. Okano, A. Ninomiya, and T. Abe Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C Gastroenterology 139 2010 1577 1585 [1585 e1571-1573]
20. C.M. Lange, D. Moradpour, A. Doehring, H.A. Lehr, B. Mullhaupt, and S. Bibert Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection J Hepatol 55 2011 322 327
21. E. Cisneros, I. Banos, M.J. Citores, A. Duca, C. Salas, and A. Noblejas Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860 Transplantation 94 2012 275 280
22. A. Duarte-Rojo, B.J. Veldt, D.D. Goldstein, H.L. Tillman, K.D. Watt, and J.K. Heimbach The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables Transplantation 94 2012 197 203
23. S. Feng, N.P. Goodrich, J.L. Bragg-Gresham, D.M. Dykstra, J.D. Punch, and M.A. DebRoy Characteristics associated with liver graft failure: the concept of a donor risk index Am J Transplant 6 2006 783 790
24. J.E. Layden, S.J. Cotler, S.A. Grim, M.J. Fischer, M.R. Lucey, and N.M. Clark Impact of donor and recipient race on survival after hepatitis C-related liver transplantation Transplantation 93 2012 444 449
25. V. Saxena, J.C. Lai, J.G. O'Leary, E.C. Verna, R.S. Brown Jr., and R.T. Stravitz Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C Liver transpl 18 2012 524 531
26. P.Y. Bochud, S. Bibert, Z. Kutalik, E. Patin, J. Guergnon, and B. Nalpas IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes Hepatology 55 2012 384 394
27. F. Marabita, A. Aghemo, S. De Nicola, M.G. Rumi, C. Cheroni, and R. Scavelli Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection Hepatology 54 2011 1127 1134
28. G. Cheng, J. Zhong, and F.V. Chisari Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms Proc Natl Acad Sci USA 103 2006 8499 8504
29. T. Saito, R. Hirai, Y.M. Loo, D. Owen, C.L. Johnson, and S.C. Sinha Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2 Proc Natl Acad Sci USA 104 2007 582 587
30. T.J. Urban, A.J. Thompson, S.S. Bradrick, J. Fellay, D. Schuppan, and K.D. Cronin IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C Hepatology 52 2010 1888 1896
31. Y. Asahina, K. Tsuchiya, M. Muraoka, K. Tanaka, Y. Suzuki, and N. Tamaki Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response Hepatology 55 2012 20 29
32. S.L. Pulit, B.F. Voight, and P.I. de Bakker Multiethnic genetic association studies improve power for locus discovery PLoS One 5 2010 e12600
33. H. Tang, T. Quertermous, B. Rodriguez, S.L. Kardia, X. Zhu, and A. Brown Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies Am J Hum Genet 76 2005 268 275
34. H.R. Rosen, J.J. Lentz, S.L. Rose, J. Rabkin, C.L. Corless, and K. Taylor Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation Transplantation 68 1999 1898 1902
35. L. Chen, I. Borozan, J. Sun, M. Guindi, S. Fischer, and J. Feld Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection Gastroenterology 138 2010 1123 1133 [e1121-1123]
36. A. Balagopal, D.L. Thomas, and C.L. Thio IL28B and the control of hepatitis C virus infection Gastroenterology 139 2010 1865 1876